Document Detail


Effect of Lactobacillus fermentum on beta2 toxin production by Clostridium perfringens.
MedLine Citation:
PMID:  21602389     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Clostridium perfringens, although a member of the normal gut flora, is also an important cause of intestinal disease in animals and, to a lesser extent, in humans. Disease is associated with the production of one or more toxins, and little is known about environmental influences on the production of these toxins. One of the health-promoting effects of lactic acid bacteria (LAB) is the establishment and maintenance of a low pH in the intestine since an acidic environment inhibits the growth of many potentially harmful bacteria. Here, the effect of the LAB Lactobacillus fermentum on beta2 toxin production by C. perfringens is described. Coculturing of C. perfringens with L. fermentum showed that under in vitro conditions, L. fermentum was capable of silencing beta2 toxin production by C. perfringens without influencing bacterial viability. The reduction in toxin production was shown to be most likely a result of the decline in pH. Quantitative PCR showed that the reduction in beta2 toxin production was due to a decrease in cpb2 mRNA. These results suggest that in the intestine, the production of beta2 toxin by C. perfringens might be regulated by other members of the normal intestinal flora.
Authors:
Janneke G Allaart; Alphons J A M van Asten; Johannes C M Vernooij; Andrea Gröne
Related Documents :
14668939 - Pharmacological manipulation of glutamate transport.
3901949 - Further studies on vasopressin-induced pressor responses to kainic acid injected into t...
7673969 - Clinical evaluation of extracellular amino acids in severe head trauma by intracerebral...
2894999 - The pharmacological selectivity of three nmda antagonists.
9192289 - Nimodipine maintains in vivo the increase in gfap and enhances the astroglial ensheathm...
743629 - Ranking of excitatory amino acids by the antagonists glutamic acid diethylester and d-a...
3778479 - Evidence for direct binding of clostridium botulinum type e derivative toxin and its fr...
8103979 - Interaction of dietary protein and alpha-linolenic acid on polyunsaturated fatty acid c...
9514789 - Quantification of jasmonic acid, methyl jasmonate, and salicylic acid in plants by capi...
Publication Detail:
Type:  Journal Article     Date:  2011-05-20
Journal Detail:
Title:  Applied and environmental microbiology     Volume:  77     ISSN:  1098-5336     ISO Abbreviation:  Appl. Environ. Microbiol.     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-06-24     Completed Date:  2011-10-12     Revised Date:  2012-01-02    
Medline Journal Info:
Nlm Unique ID:  7605801     Medline TA:  Appl Environ Microbiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  4406-11     Citation Subset:  IM    
Affiliation:
Department of Pathobiology, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 1, P.O. Box 80.158, 3508TD Utrecht, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Bacterial Toxins / antagonists & inhibitors*,  biosynthesis*
Carboxylic Acids / metabolism
Clostridium perfringens / growth & development*,  metabolism*
Gene Expression / drug effects
Gene Expression Profiling
Humans
Hydrogen-Ion Concentration
Lactobacillus fermentum / growth & development*
Microbial Interactions*
Microbial Viability
Chemical
Reg. No./Substance:
0/Bacterial Toxins; 0/Carboxylic Acids; 0/cpb2 protein, Clostridium perfringens

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Functional characterization of a mucus-specific LPXTG surface adhesin from probiotic Lactobacillus r...
Next Document:  Lectin microarray reveals binding profiles of Lactobacillus casei strains in a comprehensive analysi...